4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-028856
Chief Legal Officer gave up 1,974 shares (to pay taxes)
- Chief Legal Officer acquired 6,933 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ali-Jackson Kamil · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-07 | Exercise or conversion : show line 1 in the form | +6,933 | 94,610 | D | ||
| 2018-05-07 | Shares withheld for taxes : show line 2 in the form | −1,974 | $18.10 | $35,729 | 92,636 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-05-07 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −6,933 | 5,200 | D |
Loading xslF345X03/doc4.xml…